CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis
{{output}}
Although chimeric antigen receptor (CAR) T cells have shown excellent results in treating hematological malignancies, they also cause side effects. Patients treated with CAR T cells experience persistent cytopenia or hematotox. Here, using a fully immunocompet... ...
